Table 3.
Disease Activity in 1 year (n = 190)
| Baseline disease activity, mean (s.d.) | One-year disease activity, mean (s.d.) | Difference, mean (s.d.) | ES, mean (s.d.) | SRM, mean (s.d.) | Baseline LDA, n (%) | One-year LDA, n (%) | Change to LDA, n (%) | |
|---|---|---|---|---|---|---|---|---|
| DAS28 | 3.11 (1.01) | 2.23 (0.95) | −0.89 (1.07) | 0.88 (1.05) | 0.83 (1.00) | 100 (52) | 155 (82) | 65 (34) |
| DAPSA | 17.6 (10.0) | 10.2 (9.9) | −7.4 (10.4) | 0.73 (1.04) | 0.71 (1.00) | 84 (44) | 139 (73) | 67 (35) |
| CPDAI | 3.89 (1.90) | 2.22 (1.85) | −1.68 (2.06) | 0.88 (1.08) | 0.82 (1.00) | 120 (63) | 164 (86) | 51 (27) |
| PASDAS | 4.05 (1.21) | 2.84 (1.21) | −1.21 (1.27) | 1.00 (1.05) | 0.95 (1.00) | 47 (25) | 118 (62) | 76 (40) |
| GRACE | 3.34 (1.50) | 2.22 (1.55) | −1.12 (1.35) | 0.75 (0.90) | 0.83 (1.00) | 52 (27) | 110 (58) | 63 (33) |
| MDA | 30 (16) | 91 (48) | 66 (35) |
Results shown as mean (s.d.) or n (%). CPDAI: Composite Psoriatic Disease Activity Index; DAPSA: Disease Activity index for PSoriatic Arthritis; DAS28: Disease Activity Score 28; ES: Effect Size; GRACE: GRAppa Composite ScorE; LDA: Low Disease Activity; MDA: Minimal Disease Activity; PASDAS: psoriatic arthritis disease activity score; SRM: Standardized Response Mean.